This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Parliament is calling for regulators to audit pharmaceuticalcompanies that have made misleading statements to the public about their Covid-19 vaccines. The oversight body noted the communications had not been subject to the regulatory approval process. A member of the U.K.
Humans are diverse and communications to engage us need to be inclusive. Page & Page’s Lisa Jane Lishman outlines why communication and the strategies behind it need to be more personal to ensure that people – whoever they are – feel valued and respected. Today, people are culturally, socially, and demographically diverse.
Amid the turmoil and the race to not only find a vaccine but also help to care for those who are battling the long-term effects of COVID-19, healthcare organisations need to sharpen their communication skills. Good, empathetic design allows the science to shine.
It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access, and innovation.
To ensure people in LMICs have access to new and innovative medicines and vaccines as soon as possible after launch, companies need to have an access plan in place for products in the pipeline from at least Phase II of R&D. The research showed 83 percent of pharmaceuticalcompanies are putting more strategies in place.
People can opt out of the scheme by filling in a form and taking it to their GP before 23 June, but campaigners say this has not been communicated effectively. The government’s last attempt to shake up patient data-sharing – 2013’s Care.data scheme – suffered from a number of false starts and was eventually shut down in 2016. .
The UK pharma sector should emerge from COVID-19 with a great deal of goodwill in the bank, especially after rapidly developing vaccines that are helping to steer the world out of the pandemic. This momentum with collaboration and partnership, both with other companies within the industry, as well as external bodies, cannot be lost.
RSV researchers at major pharmaceuticalcompanies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceuticalcompanies are pushing to develop drugs and vaccines for RSV with these populations in mind.
In early 2020, health officials were cautious about forecasting a COVID-19 vaccine timeline to the public, as vaccine discovery was a historically laborious process that took years (if not decades). Yet a successful COVID-19 vaccine gained emergency approval in just 11 months, a blistering pace that likely saved millions of lives.
Trend #1: Media and Tech: Facilitating Communication. The pharmaceutical industry is making it a high priority to be transparent with their audience and help their patients feel as comfortable as possible while getting the care they need. For example, people mistrust the efficiency and safety of the COVID-19 vaccine.
In office/in person sales promotion, the staple of pharmaceuticalcompany activities, is simply not possible today with interactions reduced to the sporadic video or to telephone engagement. Understanding how to modify communication style is a first step.
To combat such challenges, pharmaceuticalcompanies need to adopt processes that are not just efficient, but agile. Empowering labs with automated equipment that produces rich, traceable, and actionable data insights means pharmaceuticalcompanies can ensure drug production runs smoothly – even under stress.
A 2020 survey from DrugsDisclosed.com of 3,346 users of prescription and over the counter (OTC) medicines from the UK and the Nordics revealed that: more than three-quarters of patients do not trust advice from pharmaceuticalcompanies about their medication; 81% feel the pharmaceutical industry influences prescription decisions; and.
Read on for key stories from this year’s Frontiers Health conference in Italy, unlocking the promise of patient support programmes in oncology, supercharging communications with modular content, and much more. Company profile: Vinehealth. Create, approve, deploy: supercharging communications with modular content.
Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceuticalcompany – our recent interview provided some interesting insights into the changing landscape of the industry.
Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. Data will always be central to everything we do, as it has the power to communicate the potential of a new treatment to change a person’s life. About the author.
Despite this, pharmaceuticalcompanies have not won over public trust. A recent study found that only 48% of participants expressed trust in pharmaceuticalcompanies. This feeling contributes to a deep mistrust in both specific branded medications and the pharmaceutical industry producing those medications.
In this engaging panel discussion , esteemed experts delve into the vital role of real-world evidence (RWE) in driving success in the pharmaceutical domain. The session sheds light on how calculated risks and creative communication are imperative for success in this dynamic industry.
Use of these platforms was however already trending up before the crisis, and there’s every sign demand will stay high from now on, according to Sjors van den Camp, commercial director at Online Seminar – a company whose heritage in this sector goes back more than a decade. The crisis that changed everything.
If the power of the life sciences industry to innovate and collaborate were ever in doubt, the speed at which vaccines for COVID-19 were discovered, developed, trialled, approved and manufactured have confirmed just how dynamic the industry can be. So as the focus shifts from cost to value, we are now seeing cloud as a CEO agenda item.
For example, practices may collaborate with pharmaceuticalcompanies to make it easier to help patients find and enroll in financial support programmes. This may require education from and communication with pharmaceuticalcompanies and other industry stakeholders moving forward.
Putting together a quarter-billion dollar pharma company from ten mergers in four months is not for the faint-hearted – but that’s what biotech investment guru Francesco de Rubertis has achieved with his latest project Centessa. Culture changes – FUJIFILM Irvine Scientific’s COO on cell therapy, COVID vaccines and 50 years of the company.
The increase in the production of biological drugs such as vaccines, gene and cell therapies, and monoclonal antibodies, is increasing the volume of injectable drug products in the global healthcare market.
As we come up on a year and a half of the COVID-19 pandemic, with the global roll out of vaccines slowly gathering pace and big pharma riding high in the opinion charts, the biopharmaceutical sector would do well to learn lessons from the banks.
Cloud-based tools allowed pharma companies to capture and share clinical data between research teams both securely and quickly. The rest is history: vaccines were delivered worldwide in record time, saving millions of lives. Cloud computing was one of the facilitators of this shift.
With the adoption of digital technologies gaining traction in many industries, pharmaceuticalcompanies must take advantage of digitalisation within its research and development (R&D) sector. Using digital means we can streamline communications, facilitate better patient engagement, and ultimately improve retention rates.
USAID aimed to help by supporting a project called Map & Match, which looked at which digital systems were in use globally that had relevance to various aspects of the COVID-19 response, such as a vaccination system, a supply chain or logistics management system, et cetera.
Artificial intelligence can assist governments and healthcare institutions in combating pandemics , including monitoring and predicting outbreaks, speeding up diagnostics and research, repurposing existing drugs, and even accelerating vaccine design and development. AI in life sciences is a lot more than just a tool for optimization.
Why Pharmaceutical Process Validation Is Important Lets list the key benefits pharmaceutical process validation offers to drug developers: It ensures patient safety Pharmaceutical validation enables pharmaceuticalcompanies to ensure drug safety.
Unexpected geographic factors Many pharmaceuticalcompanies relying on global markets for drug materials are particularly vulnerable to shifting geopolitical situations. For instance, depending on sources in tariff-affected countries can substantially increase a pharma company’s operational expenses.
Over the past couple of years, there have been many pharma company challenges. The global pandemic created an unprecedented demand for vaccines, shut down many clinical trials, and resulted in a worldwide PPE shortage. The pharmaceutical industry still faces significant challenges and is looking for innovative solutions.
And we transformed so quickly because the key players communicated and collaborated. The aim is to work with start-up companies to generate ideas for digital therapeutics, patient support apps, and boosting research and development. About the author.
The ways in which we communicate and consume information are constantly transforming. In 2020, the challenges of the COVID-19 pandemic greatly accelerated the pace of this evolution, with wide-reaching effects on many aspects of medical communications. Q1: What are some ways in which data dissemination has evolved in 2020?
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health literacy has never been more important. When a person’s or community’s health literacy is poor, misinformation can quickly spread.
She says she is “truly amazed” about what the industry has achieved in such a short time when it comes to innovations, vaccines and treatments. “When we come together like this, innovation can happen a lot faster.”. Connect with Dr Tunnah at [link] or [link].
Not only has COVID forced companies, governments and healthcare systems to work towards approving drugs and vaccines in record times, the sector is also facing an influx of digital therapeutics and advanced drugs that don’t fit neatly into existing access frameworks. How to improve payer engagement with tailored value communication.
To take one local example, in the UK Pfizer is working with the National Schools Partnership to make its Superbugs and Vaccines education program suitable for home learning. Pfizer has four different mRNA platform vaccines in play against one-another: a radical new approach for them. About THE PLANNING SHOP.
The healthcare industry is evolving rapidly, with data and digital technologies transforming everyday communications as we know them. The customer experience will be driven by innovation in communications . Communication is possible 24/7 in the digital world. The last two years have brought about an online revolution.
After a long period of inactivity in RSV vaccine development , two pharmaceuticalcompanies are now approaching regulatory decisions for their RSV vaccines. Both Pfizer and GSK have major approval decisions regarding the use of their RSV vaccines for older adults this May.
As the prophylactic landscape for malaria has changed in recent years with vaccine approvals, major issues still remain with ensuring access in remote communities. However, making sure the vaccine reaches everyone can be challenging due to the storage requirements. The Mosquirix vaccine contains two vials.
The Association of the British Pharmaceutical Industry (ABPI) also states that “the use of animals in medical research has played and continues to play an essential role in the development of new medicines and vaccines”. The topic of animal testing remains a fiercely contentious topic in the public eye.
The Singapore Government has launched Biologics Pharma Innovation Programme Singapore (BioPIPS), which aims to increase the country’s manufacturing capacity for biologics, including recombinant proteins and vaccines. The organizations plan to use data analytics to improve manufacturing processes. Additionally, Merck & Co.
Demand for biologics, including vaccines, is at an all-time high, in the post-Covid era. There are fewer sites for cell and gene therapies and vaccines – 90 companies with 127 facilities, as per GlobalData figures. As a result, some pharmaceuticalcompanies are turning to third parties.
Today, software companies know there is a growing market to meet demand for supply chain visibility platforms. The question for pharmaceuticalcompanies is how they can best deploy their data to make supply chains more efficient. Please check your email to download the Report.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content